Claire Leurent
Private Equity Investor bei AbbVie Ventures LLC
Profil
Claire Leurent is currently a Managing Director at AbbVie Ventures LLC.
Previously, she worked as a Managing Director at Samsung Catalyst from 2018 to 2019 and as a Principal at Johnson & Johnson Innovation - JJDC, Inc. from 2019 to 2023.
She also served as a Project Manager at FORENAP Pharma SARL.
Dr. Leurent holds a doctorate from the Institute of Genetics, Molecular & Cellular Biology and an MBA from MIT Sloan School of Management, which she obtained in 2016.
Aktive Positionen von Claire Leurent
Unternehmen | Position | Beginn |
---|---|---|
AbbVie Ventures LLC
AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois. | Private Equity Investor | 01.01.2024 |
Ehemalige bekannte Positionen von Claire Leurent
Unternehmen | Position | Ende |
---|---|---|
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Private Equity Investor | 01.01.2023 |
Samsung Catalyst
Samsung Catalyst Investment ManagersFinance Samsung Catalyst (Samsung Catalyst) is a venture capital subsidiary of Samsung Venture Investment Corp founded in 2004. The firm is headquartered in Menlo Park, California. | Private Equity Investor | 01.12.2019 |
FORENAP Pharma SARL
FORENAP Pharma SARL Miscellaneous Commercial ServicesCommercial Services Located in Alsace, in the heart of Europe, Forenap Pharma is an International Contract Research Organization (CRO) combined with a 'Site Management Organization' (SMO) specialized in early Drug Development and Research in Neuroscience. Founded in 1986, FORENAP has succeeded in developing in the past 20 years a unique expertise in Central Nervous System. It currently employs 180 people. FORENAP Group is made of two main lines of skills: FORENAP Pharma: preclinical and clinical studies management as well as related business activities; FORENAP FRP: dedicated to scientific research. FORENAP proposes optimized development plans and ensures the management of preclinical, Phase I (in all therapeutic areas) and Phase II (for Central Nervous System and Cardiovascular compounds) studies. With its own 72-bed centre. FORENAP offers a 'full services package' (including 'consulting' services) to bring customers projects to success, from Drug Discovery to Marketing authorization. | Corporate Officer/Principal | - |
Ausbildung von Claire Leurent
MIT Sloan School of Management | Masters Business Admin |
Institute of Genetics, Molecular & Cellular Biology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Finance |
Samsung Catalyst
Samsung Catalyst Investment ManagersFinance Samsung Catalyst (Samsung Catalyst) is a venture capital subsidiary of Samsung Venture Investment Corp founded in 2004. The firm is headquartered in Menlo Park, California. | Finance |
FORENAP Pharma SARL
FORENAP Pharma SARL Miscellaneous Commercial ServicesCommercial Services Located in Alsace, in the heart of Europe, Forenap Pharma is an International Contract Research Organization (CRO) combined with a 'Site Management Organization' (SMO) specialized in early Drug Development and Research in Neuroscience. Founded in 1986, FORENAP has succeeded in developing in the past 20 years a unique expertise in Central Nervous System. It currently employs 180 people. FORENAP Group is made of two main lines of skills: FORENAP Pharma: preclinical and clinical studies management as well as related business activities; FORENAP FRP: dedicated to scientific research. FORENAP proposes optimized development plans and ensures the management of preclinical, Phase I (in all therapeutic areas) and Phase II (for Central Nervous System and Cardiovascular compounds) studies. With its own 72-bed centre. FORENAP offers a 'full services package' (including 'consulting' services) to bring customers projects to success, from Drug Discovery to Marketing authorization. | Commercial Services |
AbbVie Ventures LLC
AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois. | Finance |